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Engineering Biodegradable and 
Biocompatible Bio-ionic Liquid 
Conjugated Hydrogels with Tunable 
Conductivity and Mechanical 
Properties
Iman Noshadi1,2, Brian W. Walker1, Roberto Portillo-Lara1,4, Ehsan Shirzaei Sani1,  
Nayara Gomes1, Mohammad Reza Aziziyan1,5,6 & Nasim Annabi1,2,3
Conventional methods to engineer electroconductive hydrogels (ECHs) through the incorporation 
of conductive nanomaterials and polymers exhibit major technical limitations. These are mainly 
associated with the cytotoxicity, as well as poor solubility, processability, and biodegradability of their 
components. Here, we describe the engineering of a new class of ECHs through the functionalization 
of non-conductive polymers with a conductive choline-based bio-ionic liquid (Bio-IL). Bio-IL 
conjugated hydrogels exhibited a wide range of highly tunable physical properties, remarkable in 
vitro and in vivo biocompatibility, and high electrical conductivity without the need for additional 
conductive components. The engineered hydrogels could support the growth and function of primary 
cardiomyocytes in both two dimentinal (2D) and three dimensional (3D) cultures in vitro. Furthermore, 
they were shown to be efficiently biodegraded and possess low immunogenicity when implanted 
subcutaneously in rats. Taken together, our results suggest that Bio-IL conjugated hydrogels could be 
implemented and readily tailored to different biomedical and tissue engineering applications.
Hydrogels are three dimensional (3D) polymeric networks made from hydrophilic, natural or synthetic poly-
mers, which are rendered insoluble by using different types of crosslinking mechanisms1. They are widely used 
for several biomedical applications due to their resemblance to the native extracellular matrix (ECM), as well as 
their remarkable biocompatibility, and tunable mechanical and biochemical properties2, 3. However, hydrogels are 
typically non-conductive, which limits their application as bioactive scaffolds for excitable tissues, such as neural, 
as well as cardiac, and skeletal muscle tissues4. More recently, hydrogels with electroconductive properties have 
been developed through the incorporation of different nanomaterials (e.g. gold nanoparticles, silver nanowires, 
carbon nanotubes, graphene oxide (GO)) and conductive polymers (e.g. polyaniline, polypyrrole (PPy), polyth-
iophene) to their network5–11. These electroconductive hydrogels (ECHs) constitute a class of smart biomaterials 
that combine the electrical properties of intrinsically conductive elements, with highly hydrated, and biocompat-
ible hydrogel networks1.
Due to the responsiveness of several tissues to electrical stimulation, the use of ECHs and conductive pol-
ymers has been explored for various biomedical applications, such as electrochemical biosensors12–14, and 
electro-responsive drug delivery systems15–17. In addition, ECHs have been extensively used as tissue engineered 
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scaffolds to promote cellular adhesion, proliferation, differentiation, and growth, as well as the electroactive mod-
ulation of different cell types, including neurons, cardiomyocytes (CMs), cardiac fibroblasts (CFs), preosteoblasts, 
endothelial cells, and mesenchymal stem cells (MSCs)18–23. As a materials platform for tissue engineering, the 
physical properties of ECHs, such as their mechanical properties, water uptake capability, porosity, and degra-
dation rate can influence tissue regeneration in vivo24, 25. In addition, excessive water uptake has been shown to 
impair the conductivity of ECHs, due to the percolation of fluids across the polymer network23. Therefore, several 
approaches have been used to modulate the conductivity and physical properties of ECHs, including the incorpo-
ration of different base polymers, bioactive components, porogens, and hydrophilic or hydrophobic moieties, as 
well as variations on the degree of crosslinking within the polymer networks26–28.
Despite the wide application of ECHs and conductive polymers for biomedical applications, they still exhibit 
major technical limitations, including the absence of cell binding sites, cytotoxicity, as well as poor solubility, 
processability, and biodegradability5–11. In addition, conventional strategies used to synthesize ECHs often suffer 
from difficult and prolonged processing, harsh reaction conditions, and difficulties in the incorporation of the 
conductive materials, and modulation of their physical properties. For example, we have previously reported the 
incorporation of GO nanoparticles into methacryloyl-substituted tropoelastin (MeTro) hydrogels for cardiac tis-
sue engineering29. Although the resulting scaffolds could support the function of primary CMs in vitro, the ability 
to finely tune their mechanical properties and conductivity was limited. In addition, the appropriate dispersion of 
conductive nanomaterials in polymeric matrices remains technically challenging30–32. Other studies have reported 
that conductive polymers such as polyaniline, are associated with increased cytotoxicity and overexpression of 
pro-inflammatory cytokines in vitro33, 34. Therefore, there is an unmet need for the development of biocompatible, 
biodegradable, and electroconductive biomaterials with highly tunable electrical and physical properties.
Ionic liquids (ILs) are organic salts with a low melting point and high water solubility, as well as high ionic con-
ductivity and electrochemical stability35. Recently, ILs have emerged as promising alternatives in the field of mate-
rial synthesis, due to their high thermal stability, ionic conductivity, and electrochemical stability36. Among the 
variety of ILs, choline-based bio-ionic liquids (Bio-ILs) have gained much interest due to their enhanced biocom-
patibility35, 37. Choline is a precursor of the phospholipids that comprise biological cell membranes in mammalian 
and plant tissues, such as phosphatidylcholine and sphingomyelin. In addition, previous studies have shown that 
choline can be decomposed both physiologically and environmentally to smaller chain molecules38. Consequently, 
choline-based Bio-ILs have been extensively investigated as non-toxic components for numerous applications39–41. 
Unlike conventional ILs, Bio-ILs are biodegradable and non-cytotoxic, as they are comprised solely of natu-
rally derived compounds35. Bio-ILs have been used as biocompatible materials for various applications, such as 
multi-responsive drug delivery systems42, solvents for biopolymers43, as well as ion gels for sensors and actua-
tors44. In the present work, we introduce a new class of photocrosslinkable ECHs, through the conjugation of 
different polymers with a conductive choline-based Bio-IL. This approach provides intrinsic conductivity to the 
polymer network, without the need for additional electroconductive components. ECHs with different mechanical 
and electroconductive profiles were generated through Bio-IL conjugation of two widely used photocrosslinka-
ble polymers (i.e., gelatin methacryloyl (GelMA) and poly(ethylene glycol) diacrylate (PEGDA)). In contrast to 
conventional methods based on ultraviolet (UV)-activated photocrosslinking, Bio-IL conjugated hydrogels with 
tunable conductivity and mechanical properties were rapidly formed via exposure to visible light. We assessed 
the ability of the composite hydrogels to promote the adhesion, proliferation, and electromodulation of primary 
CMs in vitro. We also evaluated the capability of Bio-IL conjugated hydrogels to propagate electrical stimuli and 
restore synchronous contraction in severed skeletal muscle ex vivo. We also investigated the biodegradability and 
immunogenicity of the engineered ECHs via subcutaneous implantation in an animal model. This new class of 
electroconductive polymer/Bio-IL hydrogel system holds remarkable potential for tissue engineering applications, 
due to their tunable properties, as well as their in vitro and in vivo biocompatibility and biodegradability. In addi-
tion, due to their intrinsic electroconductive properties they can also be used to engineer flexible and stretchable 
electronics for biomedical applications, including epidermal sensors, smart sutures, artificial electronic muscles, 
neuron-to-machine interfaces, and implantable medical devices. Furthermore, the approach described here can 
potentially be used to engineer ECHs from different photocrosslinkable polymers such as collagen, elastin-like 
polypeptides, tropoelastin, hyaluronic acid, alginate, polyvinyl alcohol (PVA), polycaprolactone (PCL), etc.
Synthesis of Bio-IL conjugated ECHs
Herein, we describe a versatile method to conjugate choline-based Bio-ILs to both natural and synthetic pol-
ymers, to yield biodegradable and biocompatible ECHs (Figs 1 and S1). GelMA biopolymer was synthesized 
according to a methodology reported previously45. The Bio-IL was synthesized based on the reaction between 
choline bicarbonate and acrylic acid (Fig. 1a). Different ratios of GelMA and Bio-IL were then mixed at room 
temperature. The resulting GelMA/Bio-IL prepolymer was then crosslinked into a hydrogel via visible-light 
initiated photopolymerization, using Eosin Y, vinyl caprolactone (VC), and triethanolamine (TEOA) (Fig. 1b). 
Composite hydrogels were synthesized using 100/0 (control), 80/20, 50/50, and 20/80 polymer/Bio-IL ratios at 
10%, 15% and 20% (w/v) final polymer concentrations.
The acrylation of choline bicarbonate was confirmed by comparing the proton nuclear magnetic resonance 
(1H NMR) spectra of choline bicarbonate with that of the choline acrylate (Bio-IL) as shown in Figure S2. The 
appearance of a peak related to the hydrogen atoms in the acrylate groups at δ = 5.8–6.1 ppm was indicative 
of the acrylation of choline bicarbonate (Figs 1c and S1c). In addition, the 1H NMR spectra were collected for 
GelMA prepolymer (Fig. 1d), and GelMA/Bio-IL composite hydrogel (Fig. 1e) to confirm the conjugation of 
Bio-IL to GelMA. We used Equation 1 to calculate the continuous decrease of the C=C double bond signal in the 
GelMA methacrylate groups after exposure to visible light. By comparison between 1H NMR spectra of GelMA 
prepolymer (Fig. 1d) and GelMA/Bio-IL composite hydrogel (Fig. 1e), it was found that 94.1 ± 4.6 % of the meth-
acrylate groups in GelMA/Bio-IL composites disappeared after photocrosslinking. In addition, 57.4 ± 4.3 % of the 
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peak area related to C=C double bonds of the acrylate groups in Bio-IL (Fig. 1c) also disappeared in composite 
GelMA/Bio-IL hydrogels following crosslinking (Fig. 1e). This can confirm the incorporation of both Bio-IL and 
GelMA in the resulting composite hydrogel. The appearance of a sharp peak at δ = 3.1–3.2 ppm in the composite 
hydrogel (Fig. 1e), corresponding to the three hydrogen atoms of choline (ammonium ion), could also confirm 
the conjugation of Bio-IL to the hydrogel network. This peak was absent in the GelMA prepolymer spectrum 
(Fig. 1d), but it was observed in both the Bio-IL (Fig. 1c) and the composite GelMA/Bio-IL hydrogel (Fig. 1e). 
Similarly, as shown in Figure S1, the choline peaks (d = 3.1–3.2 ppm) were also observed in PEGDA/Bio-IL 
hydrogels, indicating the conjugation of Bio-IL to PEGDA.
Figure 1. Synthesis and characterization of Bio-IL functionalized GelMA hydrogels. The panels show 
schematics of the proposed reactions for (a) the acrylation of choline bicarbonate to form Bio-IL, and (b) 
the reaction between GelMA and Bio-IL in the presence of Eosin Y and visible light to form GelMA/Bio-IL 
hydrogel. 1H-NMR analysis of (c) Bio-IL prepolymer, (d) GelMA prepolymer, and (e) GelMA/Bio-IL composite 
hydrogel. GelMA/Bio-IL hydrogels were formed by using 1% VC, 1.5% TEOA, and 0.1 mM Eosin Y at 120 s light 
exposure.
www.nature.com/scientificreports/
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Characterization of the electroconductive properties of engineered ECHs
Conventional polymer-based hydrogels, including those based on GelMA and PEGDA, are intrinsically 
non-conductive. This characteristic limits their application for the modulation of excitable cell types, such as 
neurons and CMs. Therefore, we aimed to determine if the conjugation of a choline-based Bio-IL could provide 
electroconductive properties to these polymer-based hydrogels. Briefly, Bio-IL functionalized GelMA and PEGDA 
hydrogels were synthesized as described before, and allowed to dry for 24 h. In particular, we could not form stable 
hydrogels with 20/80 polymer/Bio-IL ratios at 10% final polymer concentration. This was likely due to the low 
concentration of polymer within the network. The partially dried hydrogels were placed in a two-probe electrical 
station connected to a Hewlett Packard 4155A Semiconductor Parameter analyzer to measure their conductivity 
(Fig. 2a). A probe was placed at each end of the hydrogels and voltage was applied in increments of 0.05 V, from 
−25 to 25 V. The variations in the current were recorded, and the conductivity was calculated using Ohm’s Law46. 
Our results demonstrated that the use of different final polymer concentrations, as well as different polymer/Bio-IL 
ratios enabled the modulation of the electrical properties of the composite ECHs. For instance, the conductivity of 
50/50 GelMA/Bio-IL hydrogels increased from 3.03 × 10−05 ± 0.72 × 10−05 S/m to 4.27 × 10−05 ± 0.21 × 10−05 S/m, 
and 5.03 × 10−05 ± 0.80 × 10−05 S/m, when the final polymer concentration was increased from 10% to 15% and 
20%, respectively (Fig. 2b). Furthermore, the conductivity of 15% GelMA/Bio-IL hydrogels increased more than 
63-fold, from 4.27 × 10−05 ± 0.21 × 10−05 S/m to 272 × 10−05 ± 27.05 × 10−05 S/m, when the GelMA/Bio-IL ratio 
was changed from 50/50 to 20/80 (Fig. 2b).
Similar to what we observed for GelMA-based hydrogels, the conductivity of 50/50 PEGDA/Bio-IL 
hydrogels also increased from 485 × 10−05 ± 54.93 × 10−05 S/m to 608 × 10−05 ± 44.85 × 10−05 S/m and 
1262 × 10−05 ± 421 × 10−05 S/m, when the final polymer concentration was increased from 10% to 15% and 
20%, respectively (Fig. 2c). In addition, the conductivity of 15% PEGDA/Bio-IL hydrogels was also increased 
from 121 × 10−05 ± 1.01 × 10−05 S/m to 608 × 10−05 ± 44.85 × 10−05 and 711 × 10−05 ± 320 × 10−05 S/m, when the 
PEGDA/Bio-IL ratio was changed from 80/20 to 50/50 and 20/80, respectively (Fig. 2c). Interestingly, hydro-
gels with 80/20 GelMA/Bio-IL ratios did not exhibit any apparent conductivity in our experiments (Fig. 2b). 
However, PEGDA-based hydrogels with the same polymer/Bio-IL ratio did show measurable levels of conduc-
tivity, at all final polymer concentrations tested (Fig. 2c). These observations suggest that the use of different 
polymers could also influence the degree of conductivity of Bio-IL conjugated hydrogels. Taken together, these 
results demonstrated that the conductivity of the engineered ECHs increased consistently by increasing the con-
centrations of Bio-IL (Fig. 2b and c). In particular, the maximum conductivity observed in our tests corresponded 
to 516 × 10−05 ± 50 × 10−05 S/m and 1,262 × 10−05 ± 420 × 10−05 S/m, for GelMA- and PEGDA-based hydrogels, 
respectively (Fig. 2b and c). These results suggest that the 20/80 GelMA/Bio-IL formulation, which exhibited a 
conductivity of 516 × 10−05 S/m, could potentially be implemented in cardiac tissue engineering applications, 
since the conductivity of the native myocardium has been shown to be approximately 500 × 10−05 S/m47, 48.
The engineering of elastic and conductive materials that retain their electrical properties under substantial 
stretching and bending, still constitutes a major technical challenge49, 50. Therefore, we aimed to investigate the 
conductivity of the Bio-IL conjugated hydrogels at different levels of stretching. No conductivity measurements 
at different strain levels could be obtained from PEGDA/Bio-IL hydrogels, since the samples broke after applying 
stretch at all polymer and Bio-IL concentrations tested. Hence, we focused our analysis solely on GelMA-based 
hydrogels. Briefly, GelMA/Bio-IL hydrogels were dried for 2 h to retain trace amounts of moisture, and maintain 
their flexibility. The samples were then stretched and the conductivity was measured at different strain levels, 
using a two-probe electrical station. These results showed that there were no statistically significant differences 
between the conductivity of hydrogels at different levels of stretching (Fig. 2d). In contrast, alternative methods 
to engineer ECHs, such as the incorporation of dispersed metallic nanoparticles, often suffer from a rapid and 
nonlinear decrease in conductivity during stretching49, 51, 52.
One of the most widely explored applications of ECHs is their use as conductive scaffolds for engineering 
excitable tissue constructs. Thus, we evaluated the potential of Bio-IL conjugated polymers to restore the prop-
agation of electrical stimuli across severed skeletal muscle tissues ex vivo. Briefly, the rectus abdominis muscles 
of female Wistar rats were explanted after euthanasia, and cut into square pieces. The tissues were placed 3 mm 
apart, in an electrically insulated polydimethylsiloxane (PDMS) mold. GelMA/Bio-IL hydrogels, as well as pure 
GelMA controls were photocrosslinked in situ, between the two pieces of tissue (Fig. 2e). Pulsed direct cur-
rent test runs were conducted by applying 50 ms square pulses at increasing frequencies, using short platinum 
wires that were positioned on one of the two pieces of muscle tissue. The induction of contraction was visually 
inspected in the sample on the opposite end of the hydrogel, after applying electrical pulses at increasing voltages 
(Supplementary Video 1). These results demonstrated that muscle tissue samples joined together using GelMA/
Bio-IL hydrogels exhibited a significantly lower excitation threshold, when compared to pure GelMA controls 
(Fig. 2f). These observations suggest that Bio-IL functionalized polymers could be used to restore functional 
integrity, in tissues in which electrophysiological communication has been interrupted. Previous works have 
demonstrated the ability of ECHs to restore electrophysiological coupling of severed skeletal muscle tissue ex vivo, 
using PPy-chitosan53 and GO/MeTro hydrogels29. However, the incorporation of the PPy polymer, as well as GO 
nanoparticles into the hydrogel networks was associated with poorly tunable conductive properties. In contrast, 
Bio-IL functionalized hydrogels exhibited a wide range of electroconductive properties (Fig. 2b and c).
Characterization of the mechanical properties of engineered ECHs
Hydrogels used in biomedical applications must provide adequate mechanical support to cells and tissues, as 
well as the effective transduction of physicochemical stimuli. In particular, mechanical cues are known to mod-
ulate key cellular functions such as cell proliferation, differentiation, migration, and apoptosis54. Here, we char-
acterized the mechanical properties of the engineered composite hydrogels. Tensile and compression tests were 
performed on Bio-IL conjugated hydrogels at different polymer/Bio-IL ratios, as well as different final polymer 
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concentrations (Figs 3, S3 and S4). Bio-IL conjugated hydrogels exhibited tunable compressive moduli in the 
range of 0.60 ± 0.20 kPa to 32.07 ± 8.61 kPa (Fig. 3a) and 1.27 ± 0.05 kPa to 178.13 ± 20.59 kPa (Fig. 3b) for 
GelMA- and PEGDA-based hydrogels, respectively. In addition, our results revealed that the compressive moduli 
for both GelMA- and PEGDA-based hydrogels increased concomitantly, by increasing the final polymer con-
centration as well as the ratio of polymer to Bio-IL. For instance, the compressive moduli of 15% GelMA/Bio-IL 
hydrogels were shown to increase from 0.60 ± 0.20 kPa to 22.10 ± 1.56 kPa, when the ratio of GelMA to Bio-IL was 
increased from 20/80 to 100/0, respectively (Fig. 3a). In addition, the compressive moduli of 50/50 GelMA/Bio-IL 
hydrogels were also increased from 2.65 ± 1.06 kPa to 5.53 ± 0.76 kPa and 8.87 ± 1.83 kPa, when the final polymer 
concentration was increased from 10% to 15% and 20%, respectively (Fig. 3a). This trend was also observed for 
PEGDA/Bio-IL hydrogels. However, the use of PEGDA-based hydrogels yielded significantly higher compressive 
Figure 2. Electrical conductivity of the engineered polymer/Bio-IL hydrogels crosslinked by visible light. 
(a) Experimental set-up of the two-probe electrical station used to measure the electrical conductivity of the 
engineered hydrogels. Conductivity measurements of Bio-IL conjugated (b) GelMA and (c) PEGDA hydrogels 
at different polymer concentrations and polymer/Bio-IL ratios (1% VC, 1.5% TEOA, 0.1 mM Eosin Y, and 120 s 
exposure to visible light were used to form GelMA and PEGDA hydrogels). (d) Electrical conductivity of 15% 
GelMA/Bio-IL composite hydrogels at 50/50 ratio, which was stretched up to 0%, 20%, 30%, and 40% strain 
level demonstrating no significant changes in conductivity after stretching. (e) Schematic of ex vivo experiments 
performed using rat abdominal muscle tissues, connected using 15% final polymer concentration and 50/50 
GelMA/Bio-IL ratio, and pure GelMA hydrogels (f) Threshold voltages at which contraction was achieved 
using 15% final polymer concentration GelMA/Bio-IL at 50/50 and 20/80 ratios, as well as pure 15% GelMA 
hydrogels. Error bars indicate standard error of the means, asterisks mark significance levels of p < 0.05 (*), 
p < 0.01 (**), and p < 0.001 (***).
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moduli, as compared to GelMA-based hydrogels (Fig. 3b). For instance, the compressive moduli of 15% PEGDA/
Bio-IL hydrogels were increased from 1.27 ± 0.06 kPa to 78.17 ± 12.80 kPa, when the ratio of PEGDA to Bio-IL 
was increased from 20/80 to 100/0, respectively (Fig. 3b). In addition, the compressive moduli of 50/50 PEGDA/
Bio-IL hydrogels were also increased from 2.17 ± 0.23 kPa to 28.73 ± 6.31 kPa and 89.83 ± 13.59 kPa, when the 
final polymer concentration was raised from 10% to 15% and 20%, respectively (Fig. 3b).
We also performed tensile tests to measure the elastic modulus of the composite hydrogels. These exhibited a 
wide range of elastic moduli, in the range of 5.20 ± 1.15 kPa to 100.77 ± 23.95 kPa (Fig. 3c) and 2.60 ± 0.46 kPa to 
172.70 ± 2.86 kPa (Fig. 3d) for GelMA- and PEGDA-based hydrogels, respectively. Similar to what we observed 
for the compressive moduli, the elastic moduli of Bio-IL conjugated hydrogels were also dependent on the final 
polymer concentration, as well as the ratio of polymer to Bio-IL. For instance, the elastic moduli of 15% GelMA/
Bio-IL hydrogels were shown to increase consistently from 5.40 ± 0.87 kPa to 89.30 ± 15.65 kPa, when the ratio 
of polymer to Bio-IL was increased from 20/80 to 100/0, respectively (Fig. 3c). Furthermore, the ultimate strain 
of GelMA/Bio-IL hydrogels were shown to increase by increasing the concentration of Bio-IL. For example, 
for 15% GelMA/Bio-IL hydrogels the ultimate strain increased from 13.93 ± 4.50% to 31.25 ± 5.10% when the 
ratio of GelMA to Bio/IL was changed from 100/0 to 20/80, respectively (Figure S4a). However, the ultimate 
stress decreased by increasing the concentration of Bio-IL. As shown in Figure S4c, the ultimate stress decreased 
from 9.97 ± 1.42 kPa to 0.97 ± 0.25 kPa when the GelMA to Bio-IL ratio was changed from 100/0 to 20/80 at 
15% final polymer concentration. In addition, the elastic moduli of 50/50 GelMA/Bio-IL hydrogels were also 
increased from 5.20 ± 1.15 kPa to 21.30 ± 5.75 kPa and 33.13 ± 4.78 kPa, when the final polymer concentration 
was increased from 10% to 15% and 20%, respectively (Fig. 3c). Once again, the use of PEGDA-based hydrogels 
yielded significantly higher elastic moduli, as compared to GelMA-based hydrogels (Fig. 3d). The elastic moduli 
of 15% PEGDA/Bio-IL hydrogels increased from 2.73 ± 0.43 kPa to 60.00 ± 15.85 kPa, when the ratio of PEGDA 
to Bio-IL was increased from 20/80 to 100/0, respectively (Fig. 3d). Similar to GelMA/Bio-IL hydrogels, the ulti-
mate strain of 15% PEGDA/Bio-IL hydrogels were shown to increase from 9.28 ± 2.26% to 59.65 ± 11.59% when 
the ratio of PEGDA to Bio/IL was changed from 100/0 to 20/80, respectively (Figure S4b). The ultimate stress 
also increased from 1.53 ± 0.40 kPa for the 20/80 ratio, to 6.10 ± 3.22 kPa for the 100/0 for 15% PEGDA/Bio-IL 
hydrogels (Figure S4d). Lastly, the elastic moduli of 50/50 PEGDA/Bio-IL hydrogels were also increased from 
2.60 ± 0.46 kPa to 13.43 ± 3.20 kPa and 54.37 ± 6.34 kPa, when the final polymer concentration was increased 
from 10% to 15% and 20%, respectively (Fig. 3d).
Taken together, our results revealed that the mechanical properties of the composite scaffolds could be effi-
ciently modulated by varying both the final polymer concentration, as well as the polymer/Bio-IL ratio. The 
Figure 3. Mechanical properties of Bio-IL conjugated GelMA and PEGDA hydrogels crosslinked with visible 
light. Compressive moduli for (a) GelMA/Bio-IL and (b) PEGDA/Bio-IL hydrogels engineered by varying 
polymer concentration and polymer/Bio-IL ratios. Elastic moduli for (c) GelMA/Bio-IL and (d) PEGDA/Bio-IL 
hydrogels with varying polymer concentration and polymer/Bio-IL ratios (1% VC, 1.5% TEOA, 0.1 mM Eosin 
Y, and 120 s light exposure were used to form GelMA and PEGDA hydrogels). Error bars indicate standard error 
of the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***).
www.nature.com/scientificreports/
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enhanced mechanical properties at higher polymer concentrations could be explained in part due to the presence 
of a greater number of available crosslinking sites55. Moreover, the engineered scaffolds present several technical 
advantages in the context of biomedical applications. For example, previous studies have demonstrated that the 
stiffness of the native human myocardium ranges from 20 kPa to 100 kPa56, 57. Therefore, the highly versatile and 
tunable mechanical properties of these biomaterials could be used to generate ECHs with varying degrees of 
stiffness, which will mimic the mechanical properties of the native cardiac tissues.
Characterization of pore size, swelling ratios and in vitro degradation of engineered 
ECHs
The porosity of the hydrogels is an important factor in the modulation of cell and tissue interactions, as well as 
in the penetration of cells into the scaffold, in both 2D culture and 3D cell encapsulation58. Therefore, we aimed 
to characterize the porosity of GelMA/Bio-IL (Fig. 4a) and PEGDA/Bio-IL (Fig. 4b) hydrogels, using scanning 
electron microscopy (SEM). SEM analysis determined that the average size of the pores in the GelMA/Bio-IL 
(Fig. 4c) and PEGDA/Bio-IL (Fig. 4d) hydrogels is also dependent on the final polymer concentration, as well as 
the polymer/Bio-IL ratio. For instance, the overall pore sizes of 50/50 GelMA/Bio-IL hydrogels decreased from 
85.1 ± 18.4 μm to 61.5 ± 13.1 μm, by increasing the final polymer concentration from 10% to 20%. Similarly, 
the dimensions of the pores decreased from 86.4 ± 20.3 μm to 39.0 ± 7.9 μm, by increasing the ratio of GelMA 
to Bio-IL from 100/0 to 20/80 at 15% final polymer concentration. Although, a similar trend could be observed 
for PEGDA/Bio-IL hydrogels, we were not able to observe any apparent pores in all 20/80 hydrogels, as well as 
50/50 hydrogels formed at 15% and 20% final polymer concentrations (Fig. 4d). Previous studies have shown that 
hydrogels with large pores allow better cell penetration, as well as new tissue formation within the microstructure 
of the scaffold, when compared to hydrogels with lower porosity58, 59. The tunable porosity of Bio-IL conjugated 
hydrogels can be used to modulate the spatial distribution of cells within the scaffolds.
In the context of tissue engineering, excessive water uptake and degradation could potentially lead to impaired 
mechanical and electroconductive properties. Therefore, we evaluated the water uptake ability and the in vitro 
degradation rate of the composite hydrogels. These results demonstrated that the maximum swellability was 
achieved after 4 h of incubation, with no further increases observed after 8 and 24 h. In addition, the swelling 
ratio after 4 h of incubation for 15% GelMA/Bio-IL (Fig. 4e) and PEGDA/Bio-IL (Fig. 4f) hydrogels, increased 
from 38.1% ± 5.0% to 83.3% ± 8.6%, and from 11.6% ± 3.6% to 185.7% ± 17.1%, respectively, by changing the 
polymer/Bio-IL ratio from 100/0 to 20/80. In general, the highest swelling ratios for GelMABio-IL (Fig. 4e) and 
PEGDA/Bio-IL (Fig. 4f) hydrogels were observed in hydrogels synthesized using a polymer/Bio-IL ratio of 20/80. 
These observations can be explained in part due to the presence of hydroxyl (-OH) and amine (-NH2) hydrophilic 
residues in the choline acrylate structure, which would lead to increased water uptake into the scaffold60. Previous 
studies have reported that the swellability of IL-based hydrogels is highly dependent on the concentration of IL 
in the system61, 62. In our experiments, the highest swelling ratio observed (223.7 ± 28.5) was lower than that 
reported for other IL conjugated polymers, such as chitosan (>400%)63. This characteristic is remarkably advan-
tageous for the implementation of Bio-IL functionalized hydrogels in the context of physiological wet tissues.
Lastly, we aimed to evaluate the in vitro degradation of the engineered composite hydrogels. For this, we 
incubated Bio-IL conjugated hydrogels in Dulbecco’s phosphate-buffered saline (DPBS) and DPBS with 10% fetal 
bovine serum (FBS), at 37 °C for 14 days. Our results showed that in vitro degradation of 15% GelMA/Bio-IL 
(Fig. 4g) and PEGDA/Bio-IL (Fig. 4h) hydrogels occurred mainly after 24 h of incubation for all polymer/Bio-IL 
ratios tested. Furthermore, the results also showed that the rate of degradation decreased consistently, by increas-
ing the ratio of polymer to Bio-IL. After 14 days of incubation in DPBS supplemented with 10% FBS, 52.70 ± 4.24 
% of 20/80 PEGDA/Bio-IL hydrogel degraded, which was considerably higher than 36.59 ± 3.95 % of 20/80 
GelMA/Bio-IL hydrogel. This general trend was also observed for 10%, and 20% GelMA/Bio-IL (Figure S5) and 
PEGDA/Bio-IL (Figure S6) hydrogels at varying polymer/Bio-IL ratios, both in DPBS and DPBS supplemented 
with 10% FBS. In general, composite hydrogels containing lower concentrations of Bio-IL exhibited slower deg-
radation rates after 1, 7 and 14 days of incubation. It is important to note that the due to the organic nature of 
this compound, the degradation of the Bio-IL functionalized hydrogels will not result in the generation of any 
cytotoxic byproducts35.
Taken together, the physical characterization of Bio-IL conjugated hydrogels demonstrated that the microar-
chitecture, electrical conductivity, porosity, and in vitro degradation can be modulated by varying the final poly-
mer concentration, as well as the polymer/Bio-IL ratio. This remarkable degree of tunability suggests that Bio-IL 
conjugated hydrogels could be readily tailored to different biomedical and tissue engineering applications.
In vitro 2D cell seeding on the engineered GelMA/Bio-IL hydrogels
Hydrogels with electroconductive properties possess a remarkable potential for tissue engineering, since they can 
serve as bioactive scaffolds to modulate excitable cell types. In particular, the use of various synthetic and natural 
biomaterials has been investigated for the engineering of functional tissue constructs for different tissue engineer-
ing applications64, 65. Naturally derived polymers, such as collagen and its denatured form gelatin, have been shown 
to efficiently promote the attachment, proliferation, and migration of various cell types in vitro2, 66. This is mainly 
due to the presence of cell-binding motifs and protease-sensitive degradation sites that modulate the attach-
ment of cells to the ECM in vivo. In contrast, synthetic materials such as PEG and its acrylated form, PEGDA, 
exhibit no intrinsic cell-binding activity due to inert nature of PEG-based polymers67. Therefore, we aimed to 
investigate the potential of GelMA/Bio-IL conjugated hydrogels to support the growth, spreading and function 
of primary rat CMs in 2D cultures in vitro. A commercial live/dead assay was used to determine the viability of 
CMs growing on the surface of GelMA (Figure S7a) and GelMA/Bio-IL (Figure S7b) hydrogels, over a period of 5 
days. Similarly, cell attachment and spreading on GelMA (Figure S7c) and GelMA/Bio-IL (Figure S7d) hydrogels 
were evaluated through F-actin/DAPI immunofluorescent staining. We also investigated the ability of GelMA/
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Bio-IL scaffolds to maintain the native phenotype and function of primary CMs in 2D cultures in vitro. For 
this, we evaluated the expression of the cardiac differentiation marker sarcomeric α-actinin (Figures S7h and i), 
as well as the contractile behavior (Figure S7j) of primary CMs seeded on the surface of 15% (w/v) GelMA and 
Figure 4. Pore characteristics, in vitro swelling, and degradation of polymer/Bio-IL hydrogels. Representative 
SEM images of (a) GelMA/Bio-IL and (b) PEGDA/Bio-IL hydrogels formed by using 100/0 and 50/50 polymer/
Bio-IL ratio at 15% (w/v) polymer concentration (1% VC, 1.5% TEOA, and 0.1 mM Eosin Y at 120 s light exposure 
were used to form the hydrogels). Average pore sizes of (c) GelMA/Bio-IL and (d) PEGDA/Bio-IL hydrogels at 
varying polymer concentrations and polymer/Bio-IL ratios. Swelling ratios of (e) GelMA/Bio-IL and (f) PEGDA/
Bio-IL hydrogels at 15% final polymer concentration and 50/50 polymer/Bio-IL ratio in DPBS after 4, 8 and 24 h. 
Degradation of (g) GelMA/Bio-IL and (h) PEGDA/Bio-IL hydrogels at 15% final polymer concentration and 
50/50 polymer/Bio-IL ratio in DPBS supplemented with 10% FBS over a two-week period. Error bars indicate 
standard error of the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***).
www.nature.com/scientificreports/
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50/50 GelMA/Bio-IL hydrogels. Our results demonstrated that the viability of CMs seeded on engineered hydro-
gels was not affected due to the presence of the Bio-IL (Figure S7e). Cells seeded on the surface of GelMA/Bio-IL 
hydrogels appeared to exhibit slightly lower viabilities at day one post-seeding, when compared to GelMA con-
trols. However, there were no statistically significant differences between the composite scaffolds and the controls, 
at days 3 and 5 post-seeding. Furthermore, the metabolic activity of the primary cultures was shown to increase 
consistently throughout the duration of the culture, as shown by the commercial PrestoBlue assay (Figure S7f). 
This behavior could be explained in part due to the adaptation of the CMs to the conditions in vitro, as well as 
the proliferation of CFs that could not be removed during CM isolation. In addition, GelMA/Bio-IL hydrogels 
contained significantly higher cell numbers than pure GelMA controls at day 5 post-seeding, as shown by quan-
tification of DAPI-stained cell nuclei (Figure S7g).
CMs maintained in 2D environments tend to revert to a less mature phenotype and lose the ability to respond 
to physiological stimuli68. Thus, apart from the maintenance of metabolically active cells, the preservation of the 
native phenotype is critical to promote the spatial and functional organization of CMs69. Immunofluorescent 
staining revealed that primary CMs on the surface of GelMA/Bio-IL hydrogels exhibited homogeneous distri-
bution of sarcomeric α-actinin (Figure S7i), compared to the intermittent pattern observed in GelMA controls 
(Figure S7h). Moreover, these images also showed that CMs were arranged in spatially-relevant multi-cellular 
organizations and exhibited characteristic cross-striations after 7 days of culture, which are indicative of the sar-
comeric structures present in the native ventricular myocardium. In addition, CMs growing in GelMA/Bio-IL 
hydrogels exhibited a more robust and stable spontaneous contraction profile, when compared to CMs growing 
on GelMA controls (Figure S7j). For example, on day 7, the beating frequency of CMs seeded on GelMA/Bio-IL 
was 83.05 ± 9.54 beats/min, which was significantly higher than the beating frequency of cells seeded on pure 
GelMA hydrogels (52.61 ± 5.43 beats/min). These results suggested that GelMA/Bio-IL hydrogels promoted the 
formation of interconnected cellular networks on the surface of the scaffolds, which in turn aided to maintain 
tissue-level function of primary CMs in vitro.
Although PEGDA/Bio-IL hydrogels could not be used for cell culture due to the intrinsic inert nature of 
PEGDA, previous groups have reported the modification of PEG-based hydrogels via tethering of bioactive 
motifs, such as the incorporation of Arg-Gly-Asp (RGD) and matrix metalloproteinase-sensitive degradation 
domains70–72. These modifications have been shown to enhance the cell-binding ability and the biodegradability 
of PEG-based hydrogels for tissue engineering applications. Furthermore, due to their intrinsic resistance to 
cell adhesion and protein adsorption, PEG-based hydrogels exhibit minimal adverse host responses and highly 
specific bioactivity via the conjugation of specific bioactive agents73. The intrinsic differences between PEGDA 
and GelMA polymers clearly demonstrate the remarkable potential of Bio-IL functionalization to engineer new 
conductive biomaterials with a wide range of biological and physicochemical properties, which can be tailored 
for different biomedical applications.
3D encapsulation of primary CMs/CFs inside the engineered GelMA/Bio-IL hydrogels
Biomaterial-based cardiac tissue models that rely on 2D cultures of primary CMs have been extensively reported 
in the literature to investigate many cellular and biochemical mechanisms relevant for cardiac physiology64. More 
recently, in vitro models with increased physiological relevance have been engineered to recapitulate the interac-
tions between different cell types and the 3D architecture of native tissues74. However, encapsulation of primary 
cardiac cells in highly biocompatible ECHs with tunable electroconductive and mechanical properties has not 
been fully explored. Here, we investigated the ability of GelMA/Bio-IL hydrogels to support the growth and 
function of 3D encapsulated CMs and CFs in vitro. Similar to 2D cultures, we used a live/dead assay, F-actin/
DAPI staining, and a PrestoBlue assay to determine the viability (Fig. 5a–d), spreading (Fig. 5e–h), and metabolic 
activity (Fig. 5j) of 3D encapsulated cells in 15% (w/v) 50/50 GelMA/Bio-IL hydrogels, respectively. Although the 
overall viability of 3D encapsulated cells was comparatively lower than that observed for 2D cultures (Figure S7e), 
cells in GelMA/Bio-IL hydrogels exhibited significantly higher viabilities as compared to pure GelMA hydrogels 
(Fig. 5i). In addition, our results also showed that the metabolic activity of cells encapsulated in GelMA/Bio-IL 
hydrogels increased consistently during the 5 days of culture (Fig. 5j). However, no significant differences between 
GelMA/Bio-IL hydrogels and GelMA controls were observed regarding the proliferation of 3D encapsulated 
cells (Fig. 5k). Lastly, similar to what we observed for 2D cultures, our results demonstrated that CMs encapsu-
lated in GelMA/Bio-IL hydrogels exhibited comparatively better contractile profiles as compared to pure GelMA 
controls (Fig. 5l). Overall, in vitro assessment of GelMA/Bio-IL hydrogels demonstrated that the engineered 
ECHs are cytocompatible and promote cell growth and spreading in 3D cultures in vitro. Although no statis-
tically significant differences in cell numbers could be observed (Fig. 5k), our results showed that the viability 
(Fig. 5i) and metabolic activity (Fig. 5j) of CMs/CFs 3D encapsulated in GelMA/Bio-IL hydrogels were higher, 
when compared to pure GelMA controls. The mechanism underlying the improved growth of 3D encapsulated 
CMs in GelMA/Bio-IL hydrogels was not investigated in this study. However, previous studies have described 
that electrical stimuli could influence cell fate, through the modulation of the calcium/calmodulin pathway75, 76. 
Briefly, electrical stimuli propagate across the cell membrane, raising the intracellular calcium concentration by 
activating voltage-gated calcium channels. Elevated intracellular calcium levels activate the cytoskeletal form of 
calmodulin, which results in enhanced proliferation and increased expression of vascular endothelial growth 
factor (VEGF), and transforming growth factor (TGF)-ß77. This characteristic of GelMA/Bio-IL hydrogels could 
be critical in the restoration of impaired electrical conductivity and tissue function in scarred peri-infarct regions.
In vitro 3D co-cultures of CMs and CFs have been explored to engineer myocardial tissue constructs for 
drug screening and tissue engineering applications78–80. However, the successful 3D encapsulation of CMs/CFs 
in highly biocompatible hydrogels with tunable mechanical and electroconductive properties has not been fully 
explored. Apart from material biocompatibility, the integration of physiological stimuli is critical to promote 
growth, survival, and the functional organization of excitable cell types, such as nerve and muscle69, 81. After 
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Figure 5. In vitro 3D encapsulation of cardiomyocytes (CMs) and cardiac fibroblasts (CFs) in GelMA/Bio-IL 
hydrogels. CMs and CFs (2:1 ratio) were 3D encapsulated inside visible light-crosslinked GelMA (control) and 
GelMA/Bio-IL hydrogels. Representative live/dead images from CMs/CFs encapsulated in GelMA (a,b) and 
GelMA/Bio-IL (c,d) hydrogels at days 1 and 7 post-encapsulation. Representative F-Actin/DAPI fluorescent 
images of CMs/CFs encapsulated in GelMA (e,f) and GelMA/Bio-IL (g,h) hydrogels, at days 1 and 7 post-
encapsulation (scale bar = 200 μm). (i) Quantification of cell viability for 3D encapsulated CMs/CFs at days 1, 
4, and 7 post-encapsulation. (j) Quantification of metabolic activity, relative fluorescence units (RFU), using 
PrestoBlue assay at days 1, 4, and 7 post-encapsulation. (k) Quantification of cell proliferation based on DAPI-
stained cell nuclei at days 1, 4, and 7 post-encapsulation. (l) Characterization of synchronous contraction of 
CMs/CFs encapsulated in GelMA (control) and GelMA/Bio-IL hydrogels over 7 days of culture. (*p < 0.05, 
**p < 0.01, ***p < 0.001 and ****p < 0.0001). All hydrogels were synthesized using 15% (w/v) final polymer 
concentration and 50/50 GelMA/Bio-IL ratio. Error bars indicate standard error of the means, asterisks mark 
significance levels of p < 0.05 (*)p < 0.01 (**), and p < 0.001 (***).
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myocardial infarction, the nonconductive nature of the resulting scar tissue leads to ventricular dysfunction, as 
well as the electrical uncoupling of viable CMs in the infarcted region82. Due to the limited regenerative potential 
of adult CMs, several regenerative cardiac tissue engineering approaches have been developed using two main 
strategies: cell-based and/or material-based scaffolds83. However, one of the major limitations of conventional 
biomaterial-based approaches is that the insulating polymeric scaffolds diminish the transfer of electrical signals 
between CMs, which could lead to arrhythmias after implantation84. Thus, ECHs could be used to engineer scaf-
folds that promote impulse propagation and synchronize contraction, which in turn could help restore ventricu-
lar function by electrically coupling isolated CMs to the native tissue53.
In vivo biodegradation and biocompatibility of GelMA/Bio-IL hydrogels
One of the limitations of conventional conductive polymers is that they are often not biodegradable in vivo, which 
could trigger a persistent inflammatory response due to their prolonged half-lives in the organism19. We investi-
gated the in vivo degradation and interactions of GelMA-Bio-IL hydrogels with the local tissues, as well as their 
immunogenicity profile when implanted subcutaneously in vivo in an animal host. Explanted samples, recovered 
at days 4, 14, and 28 post-implantation, revealed that GelMA/Bio-IL hydrogels exhibited sustained biodegrada-
tion throughout the duration of the 28-day experiment (Fig. 6a). This observation suggested that the engineered 
hydrogels were efficiently degraded in vivo, through enzymatic hydrolysis of the hydrogel matrix. Visual inspec-
tion of the explanted samples also revealed significant infiltration of host tissues within the hydrogels (Fig. 6b). 
Although complete biodegradation of the scaffold was not observed due to the length of the study, previous works 
have demonstrated that GelMA-based hydrogels contain peptide sequences that facilitate cell-mediated degrada-
tion in vivo85–87. Furthermore, the conjugation of the Bio-IL to different polymers could be used to engineer ECHs 
with varying degrees of biodegradability. For example, biomaterials with more hydrolytically-stable backbones 
such as PEGDA would result ideal for long-term applications, where a more biostable implantable scaffold is 
needed88.
One crucial characteristic of implantable hydrogel-based scaffolds for tissue engineering is their ability to 
be efficiently biodegraded, in a period of time that allows the growth of new autologous tissue. Since both the 
mechanical and electroconductive properties of Bio-IL functionalized hydrogels rely on their physical integrity, 
sustained biodegradation will certainly influence the performance of the scaffolds in vivo. However, our results 
demonstrated that the degradation rate of Bio-IL hydrogels can be readily tuned by varying the final polymer con-
centration and the polymer/Bio-IL ratio (Fig. 4g and h). As opposed to conventional methods used to engineer 
ECHs, Bio-IL functionalization provides homogeneous and intrinsic electroconductive properties to the entire 
polymer network. This in turn suggests that the decay in the mechanical and electroconductive performance 
of the engineered hydrogels is directly proportional to the degradation rate. Therefore, the biodegradability of 
Bio-IL functionalized hydrogels could be further optimized depending on the specific application, to ensure 
adequate mechanical and electroconductive performance during the desired period of time.
The biodegradability profile of GelMA/Bio-IL hydrogels allows for sustained cellular ingrowth, as well as the 
eventual replacement of the implanted sample with new autologous tissue. Accordingly, histological assessment of 
the explanted hydrogels revealed ingrowth of predominantly non-inflammatory tissue, as well as low deposition 
of a fibrous collagenous capsule (Fig. 6c–e). This observation was further confirmed by immunohistofluorescent 
analysis of the explanted samples. Fluorescent immunostaining of the CD3 antigen revealed no sustained infiltra-
tion of pro-inflammatory leukocytes (Fig. 6f–h). In addition, implantation of GelMA/Bio-IL hydrogels elicited a 
macrophage response by expression of CD68 antigen, initially at day 4; however, they were significantly reduced 
by day 28 (Fig. 6i–k). These results demonstrated that GelMA/Bio-IL hydrogels elicited minimal inflammatory 
responses in vivo. In addition, specific physiological responses could be triggered through the use of different 
biopolymers. For example, previous studies have demonstrated the remarkable suitability of GelMA-based hydro-
gels for the induction of angiogenesis89. In contrast, the conjugation of Bio-IL to the bioactive polymer alginate 
could be used for studies involving osteogenesis, as well as other bone tissue engineering applications90.
The physicochemical cues from the extracellular microenvironment play a key role in various physiological 
and pathological processes that modulate tissue function91. For example, after myocardial infarction, the noncon-
ductive nature of the resulting scar tissue leads to the electrical uncoupling of the infarcted area, and eventually to 
ventricular dysfunction82. Due to the limited regenerative potential of adult CMs, several biomaterials-based tis-
sue engineering approaches for myocardium regeneration have been developed92. However, the non-conductive 
nature of most biopolymers greatly diminishes the propagation of electrical stimuli across the scaffold84. Thus, 
biomaterials-based approaches, like the one presented in this work, could help restore ventricular function by 
mechanically and electrically coupling the area around the infarcted myocardium53. Future work will investi-
gate mechanical and electrical recoupling of impaired myocardium using GelMA/Bio-IL composite hydrogels. 
Furthermore, in addition to its role in the excitation-contraction coupling, electrical stimulation of CMs is also 
known to modulate cell proliferation and function93, 94. Therefore, the ability of GelMA/Bio-IL composite hydro-
gels to efficiently transduce multiple physiological stimuli to modulate tissue function, holds a remarkable poten-
tial for cardiac tissue engineering applications.
Conclusion
We introduced a new method to generate electroconductive polymer-based biomaterials through the conjugation 
of a choline-based Bio-IL to different polymers. This approach can be used to engineer new conductive bio-
materials from inherently non-conductive polymers with different biochemical and biophysical properties. We 
described the conjugation of a Bio-IL to the two widely used polymers GelMA and PEGDA. We demonstrated 
that the mechanical properties, coductivity, porosity, degradability, and swellability of the engineered hydrogels 
could be finely-tuned by varying the final polymer concentration, as well as the ratio of polymer to Bio-IL. We 
also investigated the ability of Bio-IL conjugated hydrogels to transduce physicochemical stimuli, and modulate 
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the growth of primary CMs in both 2D and 3D cultures in vitro. We demonstrated that the engineered hydrogels 
were highly biodegradable and biocompatible in vitro, and that they did not elicit inflammatory responses when 
implanted in vivo. Taken together, our results demonstrated that Bio-IL conjugated hydrogels could be imple-
mented and readily tailored to different biomedical and tissue engineering applications.
Figure 6. In vivo biodegradation and biocompatibility of GelMA/Bio-IL composite hydrogels using a rat 
subcutaneous model. (a,b) Evaluation of the in vivo degradation of GelMA/Bio-IL on days 0, 4, 14 and 28 post 
implantation (n = 4). (a) In vivo degradation of GelMA/Bio-IL hydrogels based on weight loss of the implants. The 
in vivo degradation profile of GelMA/Bio-IL hydrogels exhibited an approximately linear behavior throughout 
28 days after implantation. (b) Images of the GelMA/Bio-IL composite hydrogels at 0, 4, 14, and 28 days after 
implantation. (c–e) Hematoxylin and eosin (H&E) staining of GelMA/Bio-IL sections after (c) 4, (d) 14, and (e) 28 
days of implantation (scale bars = 500 µm). The H&E images shows a negligible amount of inflammatory cells.  
(f–h) Fluorescent immunohistochemical analysis of subcutaneously implanted GelMA/Bio-IL hydrogels 
showing no significant local lymphocyte infiltration (CD3) at days (f) 4, (g) 14 and (h) 28 (scale bars = 200 µm), 
and significant macrophage (CD68) presence at day (i) 4, which disappeared at days (j) 14 and (k) 28 (scale 
bars = 200 µm). Green, red and blue colors in (f–k) represent the GelMA/Bio-IL hydrogels, the immune cells, and 
the cell nuclei (DAPI). 1% VC, 1.5% TEOA, and 0.1 mM Eosin Y at 120 s light exposure were used to form the 
hydrogels. All hydrogels were synthesized using 15% final polymer concentration and 50/50 GelMA/Bio-IL ratio.
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Experimental Section
Synthesis of conductive hydrogels. ECHs were synthesized by mixing different ratios of methacrylated 
polymers and choline acrylate (Bio-IL). Bio-IL was synthesized by mixing choline bicarbonate with acrylic acid 
at a 1:1 mole ratio. The mixture was reacted at 50 °C for 5 h, then purified by evaporation overnight in a vacuum 
at room temperature. GelMA and PEGDA were the two polymers used to form ECHs with Bio-IL. GelMA was 
synthesized using a method previously described in the literature45. Briefly, 10% (w/v) gelatin solution was reacted 
with 8 mL of methacrylic anhydride for 3 h. The solution was then dialyzed for 5 days to remove any unreacted 
methacrylic anhydride, and then placed in a −80 °C freezer for 24 h. The frozen acrylated polymer was then 
freeze-dried for 7 days. The PEGDA used for this research was purchased from Sigma Aldrich (average Mn 700). 
To form polymer/Bio-IL hydrogels, the prepolymer and Bio-IL were added to distilled water at varying final 
polymer concentrations and polymer/Bio-IL ratios, then mixed with 1.5% TEOA, 1% VC, and 0.1 mM Eosin Y, 
which acted as the photoinitiators. Hydrogels were then rapidly photocrosslinked in the presence of visible light 
at a wavelength of 475 nm for 120 s, using a LS1000 FocalSeal Xenon Light Source, manufactured by Genzyme.
1H NMR characterization of GelMA/Bio-IL hydrogels. 1H NMR analyses were performed to character-
ize GelMA/Bio-IL composite hydrogels using a Varian Inova-500 NMR spectrometer. 1H-NMR spectra were 
obtained from choline bicarbonate, choline acrylate (Bio-IL), GelMA prepolymer, and GelMA/Bio-IL hydrogels. 
Methacrylated groups were identified due to the presence of peak values at δ = 5.3 and 5.7 ppm. The decreasing 
rate for the C=C double bond signals − ∂ =
∂( )C Ct( )  in methacrylate group of GelMA was associated with the extent 
of crosslinking of composite hydrogel as well as conjugation of Bio-IL to GelMA. This area decrease was calcu-
lated using the following equation:
=

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where PAb and PAa represent the peak areas of methacrylated groups before and after photocrosslinking, respec-
tively. Accordingly, PAb − PAa corresponds to the concentration of methacrylated groups consumed in the pho-
tocrosslinking process. ACD/Spectrus NMR analysis software were used to integrate the area under the peaks and 
all the data was analyzed with respect to phenyl group peaks at δ = 6.5–7.5 ppm.
Mechanical testing. Mechanical testing on engineered ECHs were performed by using an Instron 5542 
mechanical tester. Both the elastic and compressive modulus were analyzed for each of the hydrogels with vary-
ing final polymer concentration and polymer/Bio-IL ratios. Composite hydrogels were created by using PDMS 
molds, which formed rectangular hydrogels (length: 12.00 mm, width: 5.00 mm, depth: 1.25 mm) for tensile tests 
and cylindrical hydrogels (diameter: 5.5 mm, height: 4 mm) for compression tests. A volume of 70 μL of prepoly-
mer solution was used to form photocrosslinked ECHs. ECHs were allowed to swell in DPBS for 4 h at 37 °C prior 
to mechanical testing. At least 5 samples were tested for each condition.
For the compression tests, hydrogels were placed between two compression plates, and compression was 
applied to each sample at a rate of 1 mm/min. Compression (mm) and load (N) were recorded during each test 
using Bluehill software. Compression modulus was calculated as the tangent slope of the initial linear region of 
the stress-strain curve between 0 mm/mm and 0.1 mm/mm compressive strain. For the tensile tests, hydrogels 
were held between two tensile grips and stretched at a rate of 1 mm/min until failure. The elastic modulus was 
calculated as the tangent slope of the stress-strain curve. At least 5 samples were tested per condition to obtain 
average and standard deviation.
In vitro evaluation of electrical conductivity. ECHs with varying final polymer concentration and poly-
mer/Bio-IL ratios were crosslinked in a rectangular PDMS mold and allowed to dry for 24 h. Once dried, conduc-
tivity measurement was performed using a two-probe electrical station connected to a Hewlett Packard 4155A 
Semiconductor Parameter analyzer. The dimensions of each hydrogel were measured and placed in a relaxed 
state where the two probes penetrated the hydrogels - one at each end (Fig. 2a). The HP 4155A was set to measure 
current in the presence of an electrical stimulation ranging from −25 to 25 volts. The results were then analyzed 
to determine conductivity values. At least 5 samples were tested for each condition.
Ex vivo evaluation of electrical conductivity. Adult female Wistar rats were provided by the Institutional 
Animal Care and Use Committee (ICAUC) at Northeastern University (Boston, MA, USA). All experiments 
were performed in accordance with relevant guidelines and regulations. Immediately after euthanasia, the rectus 
abdominis muscles were dissected and cut into 10 × 10 mm pieces. The tissue samples were then transferred to 
a glass petri dish, and placed 3 mm apart on the opposite sides of an insulating PDMS mold (Fig. 2e). GelMA/
Bio-IL hydrogels at 50/50 and 20/80 ratios, as well as pure GelMA controls were photocrosslinked in situ to con-
nect the two pieces of tissue. 50 ms square pulses of direct current were applied to the tissue using an Agilent wave 
generator (Agilent 33220A). The electrical stimulation was applied to the samples using short platinum wires 
with 0.25 mm diameter and 99.9% trace metal basis, bought from Sigma-Aldrich (MO, USA). The threshold at 
which contraction was achieved was determined by applying increasing voltages (1–10 V) at a constant frequency 
of 1 hertz. Muscle contraction was visually inspected at each voltage, after applying electrical stimulation to the 
sample on the opposite side of the mold.
In vitro degradation test. ECHs were fabricated as previously explained for compression test. ECHs were 
then freeze-dried, weighed and were placed in 24-well plate with 1 ml of DPBS or DPBS supplemented with 10% 
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FBS solutions at 37 °C in an oven continuously for 2 weeks. The DPBS/FBS solutions were refreshed every 3 days 
to maintain constant enzyme activity. At prearranged time points (after 1, 7 and 14 days), the DPBS/FBS solutions 
were removed and the samples were freeze-dried for 24 h and weighed. The percentage degradation (D%) of the 
hydrogels was calculated using the below equation:
=
−
×D W W
W
100% %,
(2)
i t
i
where Wi is the initial dry weight of the sample and Wt is the dry weight after time t.
Swelling ratio measurements. The equilibrium swelling ratio of GelMA/Bio-IL and PEGDA/Bio-IL com-
posite hydrogels were evaluated. For this purpose, cylinder-shaped hydrogels were prepared (7 mm in diameter, 
2 mm in depth) as described previously. Prepared hydrogels were washed three times with DPBS. Then, they were 
lyophilized and weighed in dry conditions. Thereafter, the samples were immersed in DPBS at 37 °C for 4, 8 and 
24 h and weighed again after immersion. The swelling ratio and water uptake capacity of the samples were calcu-
lated as the ratio of the swelled sample mass to the mass of lyophilized sample.
SEM analysis. SEM analysis was performed to evaluate the porosity of the engineered GelMA/Bio-IL and 
PEGDA/Bio-IL hydrogels. The samples were prepared in a similar procedure as described for swelling ratio tests. 
The freeze-dried samples were then coated by gold/palladium (Au/Pd) before SEM analysis. The SEM images 
were acquired by using a Hitachi S-4800 SEM (10 kV). Pore size analysis of the GelMA/Bio-IL hydrogels was 
performed by measuring the pore sizes of at least three images of four samples (n = 50) using ImageJ software.
Primary CM isolation. Primary rat CMs were isolated from 2-day-old neonatal Sprague Dawley pups 
according to the protocol approved by the ICAUC at Northeastern University. All experiments were performed 
in accordance with relevant guidelines and regulations. Briefly, pups were quickly decapitated with scissors after 
disinfecting the neck and sternum with 70% ethanol. A vertical incision was made across the sternum to excise 
the heart, which was placed in cold Hank’s Balanced Salt Solution (HBSS) buffer. The atria and blood vessels were 
carefully removed and each heart was quartered and incubated overnight in a solution of 0.05% (w/v) trypsin in 
HBSS at 4 °C. Trypsin digestion was stopped by adding culture media, followed by shaking for 5 min at 37 °C in a 
water bath. The tissues were then serially digested in 0.1% collagenase type II solution in HBSS (10 min shaking 
incubation at 37 °C). The collagenase solution with the CMs were centrifuged at 500 × g for 5 min. Primary cells 
were resuspended in DMEM supplemented with 10% FBS and pre-plated for 1 h to enrich for cardiomyocytes.
Surface seeding (2D culture). Hydrogels were formed by placing a 7-μl drop of hydrogel precursor in 
a spacer with 150-μm height and covered by a glass slide coated with 3-(trimethoxysilyl) propyl methacrylate 
(TMSPMA, Sigma-Aldrich). Hydrogel precursors were then photocrosslinked for 20 s using a Genzyme FocalSeal 
LS100 xenon light source. Primary rat CMs (3.5 × 104 cells/scaffold) were seeded on the surface of the hydrogels 
and placed in 24-well plates with 400 μl of growth medium (DMEM supplemented with 10% fetal bovine serum 
(FBS, Invitrogen) and 1% penicillin/streptomycin (Invitrogen)). 2D cultures were maintained at 37 °C in a 5% 
CO2 humidified atmosphere, for 10 days and culture medium was replaced every 48 h.
3D cell encapsulation. Hydrogel precursors were prepared in cell culture medium containing 1.5% TEOA, 
1% VC, and 0.1 mM Eosin Y. A cell suspension containing freshly isolated CMs and CFs in culture medium (2:1 
ratio of CMs:CFs and 1.8 × 107 cells/ml total cell density) was gently mixed with an equal volume of the pre-
cursor solution. 7-µl drops were then pipetted on 150-µm thick spacers, and covered by TMSPMA-coated glass 
slides. Hydrogels were then photocrosslinked for 120 s using a Genzyme FocalSeal LS100 xenon light source, 
as described before for 2D cultures. Cell laden hydrogels were placed in 24-well plates with 400 μl of growth 
medium, and maintained at 37 °C in a 5% CO2 humidified atmosphere for 10 days.
Cell viability. The viability of primary CMs grown on the surface of GelMA and GelMA/Bio-IL hydrogels was 
evaluated using a commercial live/dead viability kit (Invitrogen), according to instructions from the manufac-
turer. Briefly, cells were stained with 0.5 μl/ml of calcein AM and 2 μl/ml of ethidium homodimer-1 (EthD-1) in 
DPBS for 15 min at 37 °C. Fluorescent image acquisition was carried out at days 1, 4, and 7 post-seeding using an 
AxioObserver Z1 inverted microscope (Zeiss). Viable cells appeared as green and apoptotic/dead cells appeared 
as red. The number of live and dead cells was quantified using the ImageJ software. Cell viability was determined 
as the number of live cells divided by the total number of live and dead cells.
Metabolic activity. The metabolic activity of the cells was evaluated at days 1, 4, 7 post-seeding, using a 
PrestoBlue assay (Life Technologies) according to instructions from the manufacturer. Briefly, 2D and 3D cultures 
of primary CMs were incubated in 400 μL of growth medium with 10% PrestoBlue reagent for 2 h at 37 °C. The 
resulting fluorescence was measured (excitation 530 nm; emission 590 nm) using a Synergy HT fluorescence plate 
reader (BioTek). Control wells without cells were used to determine the background for all experiments.
Cell adhesion, proliferation and spreading. CM spreading on the surface of the engineered composite 
hydrogels was visualized through fluorescent staining of F-actin filaments and cell nuclei. Briefly, 2D cultures 
at days 1, 4, and 7 post-seeding were fixed in 4% (v/v) paraformaldehyde (Sigma) for 15 min., permeabilized in 
0.1% (w/v) Triton X-100 (Sigma) for 5 min, and then blocked in 1% (w/v) bovine serum albumin (BSA, Sigma) 
for 30 min. Samples were then incubated with Alexa-fluor 488-labeled rhodamine-phalloidin (20/800 dilution in 
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0.1% BSA, Invitrogen) for 45 min. After three consecutive washes with DPBS, samples were counterstained with 
1 μl/ml DAPI (4′,6-diamidino-2-phenylindole, Sigma) in DPBS for 5 min. Fluorescent image acquisition was car-
ried out using an AxioObserver Z1 inverted microscope.
Immunostaining of cardiac markers. Immunocytofluorescent staining was performed on 2D cultures 
of primary CMs in order to evaluate the expression of the cardiac differentiation marker sarcomeric α-actinin. 
Briefly, CMs growing on the surface of GelMA and GelMA/Bio-IL hydrogels gel were fixed in 4% paraformal-
dehyde for 1 h at room temperature at day 7 post-seeding. Samples were washed three times with DPBS, perme-
abilized in 0.1% (w/v) Triton X-100 for 30 min, and blocked in 10% (v/v) goat serum in DPBS containing 0.1% 
Triton x-100 for 1 h. Samples were incubated overnight with anti-sarcomeric α-actinin primary antibody (1:200 
dilution) in 10% (v/v) goat serum at 4 °C. After incubation, samples were washed three times with DPBS and 
incubated for 2 h at room temperature with an Alexa Fluor 488-conjugated secondary antibody diluted in 10% 
(v/v) goat serum (1:200 dilution). Lastly, the samples were washed three times with DPBS and counterstained 
with DAPI (1/1000 dilution in DPBS) for 5 min at room temperature. Image acquisition was performed using an 
AxioObserver Z1 inverted microscope.
In vivo biodegradation and biocompatibility. All animal experiments were reviewed and approved by 
the ICAUC (protocols 15-0521R and 15-1248R) at Northeastern University, and all experiments were performed 
in accordance with relevant guidelines and regulations. Male Wistar rats (200–250 grams) were obtained from 
Charles River (Boston, MA, USA) and housed in the local animal care facility under conditions of circadian day–
night rhythm and feeding ad libitum. Anesthesia was achieved by 2.0 to 2.5% isoflurane inhalation, followed by 
0.02 to 0.05 mg/kg SC buprenorphine administration. After inducing anesthesia, eight 1-cm incisions were made 
on the posterior medio-dorsal skin, and small lateral subcutaneous pockets were prepared by blunt dissection 
around the incisions. GelMA/Bio-IL hydrogels (1 × 5 mm disks) were implanted into the pockets, followed by 
anatomical wound closure and recovery from anesthesia. Animals were euthanized by anesthesia/exsanguination 
at days 4, 14 and 28 post-implantation, after which the samples were retrieved with the associated tissue and 
placed in DPBS.
Histological analysis and immunofluorescent staining. Histological analyses were performed on 
cryosections of the explanted hydrogel samples in order to characterize the inflammatory response elicited by 
the implanted material. After explantation, samples were fixed in 4% paraformaldehyde for 4 hours, followed by 
overnight incubation in 30% sucrose at 4 °C. Samples were then embedded in Optimal Cutting Temperature com-
pound (OCT) and flash frozen in liquid nitrogen. Frozen samples were then sectioned using a Leica Biosystems 
CM3050 S Research Cryostat. 15-µm cryosections were obtained and mounted in positively charged slides using 
DPX mountant medium (Sigma). The slides were then processed for hematoxylin and eosin staining (Sigma) 
according to instructions from the manufacturer. Immunohistofluorescent staining was performed on mounted 
cryosections as previously reported29. Anti-CD3 [SP7] (ab16669) and anti-CD68 (ab125212) (Abcam) were used 
as primary antibodies, and an Alexa Fluor 594-conjugated secondary antibody (Invitrogen) was used for detec-
tion. All sections were counterstained with DAPI (Invitrogen), and visualized on an AxioObserver Z1 inverted 
microscope (Zeiss).
Statistical analysis. Data analysis was carried out using a 2-way ANOVA test with the GraphPad Prism 
6.0 software. Error bars were calculated as the mean ± standard deviation (SD) of measurements (*p < 0.05, 
**p < 0.01, and ***p < 0.001).
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